Gene · 84433
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. | Pathogens | 2023 | 36678457 | PubTator, text mining | PubMed |
| Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies. | Int J Mol Sci | 2023 | 36675253 | PubTator, text mining | PubMed |
| Successful Treatment of Large B-Cell Lymphoma in a Child with Compound Heterozygous Mutation in the ATM Gene. | Int J Mol Sci | 2023 | 36674612 | PubTator, text mining | PubMed |
| Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell Lymphoma Patients. | Clin Lab | 2023 | 36649512 | PubTator, text mining | PubMed |
| Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatment. | JCI Insight | 2023 | 36649072 | PubTator, text mining | PubMed |
| Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma. | J Oncol | 2023 | 36644235 | PubTator, text mining | PubMed |
| Microdeletions and microduplications linked to severe congenital disorders in infertile men. | Sci Rep | 2023 | 36631630 | PubTator, text mining | PubMed |
| Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma. | Cells | 2023 | 36611989 | PubTator, text mining | PubMed |
| Molecular profiling of EBV associated diffuse large B-cell lymphoma. | Leukemia | 2023 | 36604606 | PubTator, text mining | PubMed |
| Neoantigens: promising targets for cancer therapy. | Signal Transduct Target Ther | 2023 | 36604431 | PubTator, text mining | PubMed |
| Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment. | Blood Cancer J | 2023 | 36599826 | PubTator, text mining | PubMed |
| Signaling pathways in brain tumors and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36596785 | PubTator, text mining | PubMed |
| Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity. | J Allergy Clin Immunol | 2023 | 36522221 | PubTator, text mining | PubMed |
| Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency. | J Exp Med | 2023 | 36515678 | PubTator, text mining | PubMed |
| NF-κB dynamics in the language of immune cells. | Trends Immunol | 2023 | 36473794 | PubTator, text mining | PubMed |
| A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas. | Leukemia | 2023 | 36460764 | PubTator, text mining | PubMed |
| Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation. | Virchows Arch | 2023 | 36454275 | PubTator, text mining | PubMed |
| Very Early Onset Inflammatory Bowel Disease Caused by a Novel Dominant Negative Mutation of Caspase Recruitment Domain 11 (CARD11). | J Clin Immunol | 2023 | 36443613 | PubTator, text mining | PubMed |
| Lymphoma-associated mutations in autoreactive memory B cells of patients with Sjögren's syndrome. | J Pathol | 2023 | 36426826 | PubTator, text mining | PubMed |
| Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis. | Pathology | 2023 | 36420560 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84433/papers?page=18